CompletedNot Applicable

Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis

China400 participantsStarted 2012-12

Plain-language summary

To assess the efficacy and safety of local application of intraoperative mitomycin C (MMC) at osteotomy site in endoscopic dacryocystorhinostomy(EN-DCR).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. comparative studies;
✓. adult patients (\> 18 years) with NLDO undergoing primary or revision EN-DCR;
✓. all studies included were required to provide the success rates of both MMC and control groups, and the followed up time was more than 6 months.

Exclusion criteria

✕. studies which did not provide the success rates;
✕. studies which included pediatric cases.

What they're measuring

success rate

Timeframe: 6 months

Trial details

NCT IDNCT01772277

SponsorYifan Feng

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-02

View on ClinicalTrials.gov More Dacryocystitis trials